These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10419650)

  • 1. Ingested interferon alpha induces Mx mRNA.
    Brod SA; Nelson L; Jin R; Wolinsky JS
    Cytokine; 1999 Jul; 11(7):492-9. PubMed ID: 10419650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
    Brod SA; Khan M
    J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
    Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
    Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingested (oral) IFN-alpha represses TNF-alpha mRNA in relapsing-remitting multiple sclerosis.
    Brod SA; Nguyen M; Hood Z; Shipley GL
    J Interferon Cytokine Res; 2006 Mar; 26(3):150-5. PubMed ID: 16542137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1/Th2 type cytokines in hepatitis B patients treated with interferon-alpha.
    Xing T; Zhang L; Lu Q; Hou J; Feng X; Luo K
    Chin Med J (Engl); 2001 Sep; 114(9):921-4. PubMed ID: 11780382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune effects observed after the injection of plasmids coding for rainbow trout (Oncorhynchus mykiss) CK5B, CK6 and CK7A chemokines demonstrate their immunomodulatory capacity and reveal CK6 as a major interferon inducer.
    Montero J; Chaves-Pozo E; Cuesta A; Tafalla C
    Dev Comp Immunol; 2009 Oct; 33(10):1137-45. PubMed ID: 19539644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylthioadenosine reverses brain autoimmune disease.
    Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
    Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
    Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
    Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines.
    Brod SA; Hood Z
    J Neuroimmunol; 2007 Feb; 183(1-2):89-95. PubMed ID: 17196668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of MxA mRNA in patients with neuroendocrine tumors after interferon treatment. Lack of correlation with antitumor response.
    Imam H; Janson ET; Gobl A; Alm G; Oberg K
    Anticancer Res; 1995; 15(5B):2191-5. PubMed ID: 8572623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious pancreatic necrosis virus suppresses type I interferon signalling in rainbow trout gonad cell line but not in Atlantic salmon macrophages.
    Collet B; Munro ES; Gahlawat S; Acosta F; Garcia J; Roemelt C; Zou J; Secombes CJ; Ellis AE
    Fish Shellfish Immunol; 2007; 22(1-2):44-56. PubMed ID: 16713304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha.
    Jorns C; Holzinger D; Thimme R; Spangenberg HC; Weidmann M; Rasenack J; Blum HE; Haller O; Kochs G
    J Med Virol; 2006 Jan; 78(1):74-82. PubMed ID: 16299717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.
    Reuss R; Pohle S; Retzlaff K; Hemberger J; Oschmann P
    Neuroimmunomodulation; 2009; 16(3):171-6. PubMed ID: 19246939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.
    Brod SA; Khan M; Nelson LD; Decuir B; Malone M; Henninger E
    J Immunother; 2000; 23(2):235-45. PubMed ID: 10746550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.